- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1880-8190
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Neutralizing and enhancing antibodies against SARS-CoV-2 ; volume:42 ; number:1 ; day:5 ; month:12 ; year:2022 ; pages:1-9 ; date:12.2022
Inflammation and regeneration ; 42, Heft 1 (5.12.2022), 1-9, 12.2022
- Creator
-
Liu, Yafei
Arase, Hisashi
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s41232-022-00233-7
- URN
-
urn:nbn:de:101:1-2023021521141420847065
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:59 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Liu, Yafei
- Arase, Hisashi
- SpringerLink (Online service)
Other Objects (12)
Quantitation of SARS-CoV-2 neutralizing antibodies using virus-like particles
Broadly neutralizing human antibodies against Omicron subvariants of SARS-CoV-2
Converting non-neutralizing SARS-CoV-2 antibodies into broad-spectrum inhibitors
Thermodynamically coupled biosensors for detecting neutralizing antibodies against SARS-CoV-2 variants
Evaluation of SARS-CoV-2 neutralizing antibodies using a vesicular stomatitis virus possessing SARS-CoV-2 spike protein
Neutralizing Antibodies against SARS-CoV-2 and HLA Class I and II Polymorphism
Persistence of neutralizing antibodies a year after SARS‐CoV‐2 infection in humans
Unbiased approach to identify and assess efficacy of human SARS-CoV-2 neutralizing antibodies
Effective screening of SARS-CoV-2 neutralizing antibodies in patient serum using lentivirus particles pseudotyped with SARS-CoV-2 spike glycoprotein
Direct comparison of SARS-CoV-2 variant specific neutralizing antibodies in human and hamster sera
Automated detection of neutralizing SARS-CoV-2 antibodies in minutes using a competitive chemiluminescence immunoassay
Molecular deconvolution of the neutralizing antibodies induced by an inactivated SARS-CoV-2 virus vaccine
Quantitation of SARS-CoV-2 neutralizing antibodies using virus-like particles
Broadly neutralizing human antibodies against Omicron subvariants of SARS-CoV-2
Converting non-neutralizing SARS-CoV-2 antibodies into broad-spectrum inhibitors
Thermodynamically coupled biosensors for detecting neutralizing antibodies against SARS-CoV-2 variants
Evaluation of SARS-CoV-2 neutralizing antibodies using a vesicular stomatitis virus possessing SARS-CoV-2 spike protein
Neutralizing Antibodies against SARS-CoV-2 and HLA Class I and II Polymorphism
Persistence of neutralizing antibodies a year after SARS‐CoV‐2 infection in humans
Unbiased approach to identify and assess efficacy of human SARS-CoV-2 neutralizing antibodies
Effective screening of SARS-CoV-2 neutralizing antibodies in patient serum using lentivirus particles pseudotyped with SARS-CoV-2 spike glycoprotein
Direct comparison of SARS-CoV-2 variant specific neutralizing antibodies in human and hamster sera
Automated detection of neutralizing SARS-CoV-2 antibodies in minutes using a competitive chemiluminescence immunoassay
Molecular deconvolution of the neutralizing antibodies induced by an inactivated SARS-CoV-2 virus vaccine
Quantitation of SARS-CoV-2 neutralizing antibodies using virus-like particles
Broadly neutralizing human antibodies against Omicron subvariants of SARS-CoV-2
Converting non-neutralizing SARS-CoV-2 antibodies into broad-spectrum inhibitors
Thermodynamically coupled biosensors for detecting neutralizing antibodies against SARS-CoV-2 variants
Evaluation of SARS-CoV-2 neutralizing antibodies using a vesicular stomatitis virus possessing SARS-CoV-2 spike protein
Neutralizing Antibodies against SARS-CoV-2 and HLA Class I and II Polymorphism
Persistence of neutralizing antibodies a year after SARS‐CoV‐2 infection in humans
Unbiased approach to identify and assess efficacy of human SARS-CoV-2 neutralizing antibodies
Effective screening of SARS-CoV-2 neutralizing antibodies in patient serum using lentivirus particles pseudotyped with SARS-CoV-2 spike glycoprotein
Direct comparison of SARS-CoV-2 variant specific neutralizing antibodies in human and hamster sera
Automated detection of neutralizing SARS-CoV-2 antibodies in minutes using a competitive chemiluminescence immunoassay